Jan 9, 2026 09:20AM Krystal Biotech (KRYS) PT Raised to $306 at TD Cowen

Jan 9, 2026 06:59AM Krystal Biotech (KRYS) Reiterated at Market Outperform After CORAL-3 FDA Submission

Jan 9, 2026 05:12AM Krystal Biotech (KRYS) PT Raised to $288 at BofA Securities

Jan 9, 2026 03:13AM Krystal Biotech (KRYS) PT Raised to $310 at Jefferies

Jan 7, 2026 09:00PM BofA top picks in biotech as sector heading for recovery in 2026

Dec 23, 2025 04:53PM Krystal Biotech board member resigns due to promotion at Sun Pharma

Nov 3, 2025 07:02AM Krystal Biotech, Inc. (KRYS) Tops Q3 EPS by $1.57

Oct 17, 2025 05:50AM Krystal Biotech (KRYS) PT Raised to $255 at BofA Securities

Oct 14, 2025 08:03AM Krystal Biotech receives FDA platform technology designation for HSV-1 vector

Sep 16, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Sep 15, 2025 02:20PM TD Cowen Reiterates Buy Rating on Krystal Biotech (KRYS)

Aug 22, 2025 07:57AM Krystal Biotech (KRYS) PT Lowered to $216 at Chardan Capital Markets

Aug 22, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Aug 21, 2025 12:14PM Krystal Biotech prioritizes inhaled KB707 for lung cancer treatment

Aug 4, 2025 11:56AM Krystal Biotech (KRYS) PT Lowered to $182 at BofA Securities

Aug 4, 2025 07:03AM Krystal Biotech, Inc. (KRYS) Tops Q2 EPS by 7c, Beats on Revenue

Jul 25, 2025 09:01AM Krystal Biotech receives Japan approval for DEB gene therapy VYJUVEK

Jul 25, 2025 07:43AM Cantor Fitzgerald Reiterates Overweight Rating on Krystal Biotech (KRYS)

Jul 25, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Jul 10, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Jul 9, 2025 04:48PM Krystal Biotech (KRYS) PT Raised to $176 at Citi

Jul 9, 2025 07:04AM Krystal Biotech doses first patient in KB801 eye drop gene therapy trial

Jun 30, 2025 04:20PM Clear Street Starts Krystal Biotech (KRYS) at Buy

Jun 30, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Jun 25, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Jun 3, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

May 7, 2025 07:18AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

May 6, 2025 08:03AM Krystal Biotech, Inc. (KRYS) Misses Q1 EPS by 26c, provides guidance

Apr 29, 2025 07:17AM Krystal Biotech (KRYS) PT Raised to $240 at H.C. Wainwright

Apr 28, 2025 07:05AM Krystal Biotech (KRYS) Announces European Commission Approval of VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa

Apr 7, 2025 04:30PM Krystal Biotech (KRYS) Appoints Marc Forth as CEO

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 5, 2025 02:04AM Jefferies Starts Krystal Biotech (KRYS) at Buy

Mar 3, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Feb 28, 2025 07:45AM Krystal Biotech (KRYS) Receives Positive CHMP Opinion for VYJUVEK

Feb 20, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)

Feb 19, 2025 07:04AM Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 31c

Jan 14, 2025 08:04AM Krystal Biotech (KRYS) Appoints Nishant Saxena as Chief Financial Officer

Dec 28, 2024 01:00PM Kuehn Law Encourages Investors of Krystal Biotech, Inc. to Contact Law Firm

Dec 18, 2024 08:02AM Krystal Biotech (KRYS) Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

Dec 12, 2024 12:53PM BofA Securities Reiterates Buy Rating on Krystal Biotech (KRYS)

Dec 9, 2024 04:16PM Krystal Biotech (KRYS) Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

Nov 4, 2024 04:42PM Krystal Biotech (KRYS) PT Raised to $206 at Citi

Nov 4, 2024 08:02AM Krystal Biotech, Inc. (KRYS) Misses Q3 EPS by 8c

Oct 1, 2024 06:56AM Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)

Aug 30, 2024 07:59AM TD Cowen Reiterates Buy Rating on Krystal Biotech (KRYS)

Aug 29, 2024 06:42AM Krystal Biotech (KRYS) PT Raised to $221 at H.C. Wainwright

Aug 28, 2024 09:40AM Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)

Aug 28, 2024 07:01AM Krystal Biotech's (KRYS) Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301

Aug 5, 2024 08:02AM Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 25c Provides Outlook